eli lilly news glp-1 Lilly's oral pill may help people with Type 2 diabetes lose 'significant' weight, study finds Eli Lilly's Obesity Pill Appears

We found that liraglutide dosed animals showed no significant differences in disease progression when compared to vehicle dosed animals in either the SOD1G93A or TDP-43Q331K mouse models of ALS

Novo Nordisk, Boehringer Ingelheim, Hims & Hers, Novartis, Ro, and Lilly are all set to run spots during the Big Game.

Real-world data show early discontinuation of GLP-1 therapy is linked to higher risks of coronary artery disease and heart failure.

With Transform Diabetes Care, Aetna gives employers and their employees the tools, education and support to stick with diabetes treatment and manage their condition with success

Skipping meals while on semaglutide can trigger nausea, blood sugar crashes, and medication side effects that undermine your weight loss progress